Literature DB >> 21550365

Can the neuroeconomics revolution revolutionize psychiatry?

Gregor Hasler1.   

Abstract

Neuroeconomics is a rapidly growing new research discipline aimed at describing the neural substrate of decision-making using incentivized decisions introduced in experimental economics. The novel combination of economic decision theory and neuroscience has the potential to better examine the interactions of social, psychological and neural factors with regard to motivational forces that may underlie psychiatric problems. Game theory will provide psychiatry with computationally principled measures of cognitive dysfunction. Given the relatively high heritability of these measures, they may contribute to improving phenotypic definitions of psychiatric conditions. The game-theoretical concepts of optimal behavior will allow description of psychopathology as deviation from optimal functioning. Neuroeconomists have successfully used normative or near-normative models to interpret the function of neurotransmitters; these models have the potential to significantly improve neurotransmitter theories of psychiatric disorders. This paper will review recent evidence from neuroeconomics and psychiatry in support of applying economic concepts such as risk/uncertainty preference, time preference and social preference to psychiatric research to improve diagnostic classification, prevention and therapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21550365     DOI: 10.1016/j.neubiorev.2011.04.011

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  26 in total

Review 1.  Neuroeconomics: a bridge for translational research.

Authors:  Carla Sharp; John Monterosso; P Read Montague
Journal:  Biol Psychiatry       Date:  2012-07-15       Impact factor: 13.382

Review 2.  Dysfunctions of decision-making and cognitive control as transdiagnostic mechanisms of mental disorders: advances, gaps, and needs in current research.

Authors:  Thomas Goschke
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

Review 3.  Decision making: from neuroscience to psychiatry.

Authors:  Daeyeol Lee
Journal:  Neuron       Date:  2013-04-24       Impact factor: 17.173

4.  Fairness decisions in response to emotions: a functional MRI study among criminal justice-involved boys with conduct disorder.

Authors:  Eduard T Klapwijk; Gert-Jan Lelieveld; Moji Aghajani; Albert E Boon; Nic J A van der Wee; Arne Popma; Robert R J M Vermeiren; Olivier F Colins
Journal:  Soc Cogn Affect Neurosci       Date:  2016-02-29       Impact factor: 3.436

5.  Understanding mood in mental disorders.

Authors:  Gregor Hasler
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

6.  The behavioral economics of social anxiety disorder reveal a robust effect for interpersonal traits.

Authors:  Thomas L Rodebaugh; Natasha A Tonge; Jaclyn S Weisman; Michelle H Lim; Katya C Fernandez; Ryan Bogdan
Journal:  Behav Res Ther       Date:  2017-06-15

7.  Self-other resonance, its control and prosocial inclinations: Brain-behavior relationships.

Authors:  Leonardo Christov-Moore; Marco Iacoboni
Journal:  Hum Brain Mapp       Date:  2016-02-01       Impact factor: 5.038

8.  A negative emotional and economic judgment bias in major depression.

Authors:  Dirk Scheele; Yoan Mihov; Olga Schwederski; Wolfgang Maier; René Hurlemann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

9.  Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort.

Authors:  Matthias N Hartmann; Oliver M Hager; Anna V Reimann; Justin R Chumbley; Matthias Kirschner; Erich Seifritz; Philippe N Tobler; Stefan Kaiser
Journal:  Schizophr Bull       Date:  2014-07-22       Impact factor: 9.306

10.  Neural Correlates of Impaired Reward-Effort Integration in Remitted Bulimia Nervosa.

Authors:  Stefanie Verena Mueller; Yosuke Morishima; Simon Schwab; Roland Wiest; Andrea Federspiel; Gregor Hasler
Journal:  Neuropsychopharmacology       Date:  2017-11-06       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.